IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...
Though you're probably already eating insect-derived products, many more will soon be added to our food supply and the could prove problematic for those with allergies to shellfish.